{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:29:17Z","timestamp":1761128957284},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T00:00:00Z","timestamp":1323907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10067-011-1903-2","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T23:36:59Z","timestamp":1323819419000},"page":"395-398","source":"Crossref","is-referenced-by-count":9,"title":["Development of lepromatous leprosy following etanercept treatment for arthritis"],"prefix":"10.1007","volume":"31","author":[{"given":"Charalampos","family":"Lydakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Ioannidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irini","family":"Koumpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elpida","family":"Giannikaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaggelos","family":"Thalassinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Krasoudaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spiros","family":"Miyakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"1903_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261\u20131265","journal-title":"Clin Infect Dis"},{"key":"1903_CR2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10067-009-1140-0","volume":"28","author":"RV Lopes","year":"2009","unstructured":"Lopes RV, Ohashi CB, Cavaleiro LH, Cruz RBP, da Veiga RR, Miranda MFR, Yoshikawa TG (2009) Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation or latent infection? Clin Rheumatol 28:615\u2013617","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1903_CR3","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1086\/505222","volume":"43","author":"DM Scollard","year":"2006","unstructured":"Scollard DM, Joyce MP, Gillis TP (2006) Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases. Clin Infect Dis 43(2):e19\u2013e22","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1903_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archdermatol.2009.10","volume":"145","author":"ID Camacho","year":"2009","unstructured":"Camacho ID, Valencia I, Rivas MP, Burdick AE (2009) Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy. Arch Dermatol 145(3):349\u2013351","journal-title":"Arch Dermatol"},{"issue":"7","key":"1903_CR5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/art.23815","volume":"59","author":"EM Oberstein","year":"2008","unstructured":"Oberstein EM, Kromo O, Tozman EC (2008) Type I reaction of Hansen\u2019s disease with exposure to adalimumab: a case report. Arthritis Rheum 59(7):1040\u20131043","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1903_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S0482-50042010000300013","volume":"50","author":"DS Freitas","year":"2010","unstructured":"Freitas DS, Machado N, Andrigueti FV, Reis Neto ET, Pinheiro MM (2010) Lepromatous leprosy associated with the use of anti-TNF \u03b1 therapy: case report. Rev Bras Reumatol 50(3):333\u2013339","journal-title":"Rev Bras Reumatol"},{"key":"1903_CR7","first-page":"451","volume":"51","author":"DS Ridley","year":"1974","unstructured":"Ridley DS (1974) Histological classification and the immunological spectrum of leprosy. Bull WHO 51:451\u2013465","journal-title":"Bull WHO"},{"issue":"1","key":"1903_CR8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2567.2003.01630.x","volume":"109","author":"MO Hernandez","year":"2003","unstructured":"Hernandez MO, Neves I, Sales JS, Carvalho DS, Sarno EN, Sampaio EP (2003) Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha. Immunology 109(1):156\u2013164","journal-title":"Immunology"},{"issue":"Suppl 3","key":"1903_CR9","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/429998","volume":"41","author":"S Ehlers","year":"2005","unstructured":"Ehlers S (2005) Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? Clin Infect Dis 41(Suppl 3):S199\u2013S203","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1903_CR10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00296-008-0836-9","volume":"29","author":"JY Kim","year":"2009","unstructured":"Kim JY, Park JN, Lee JG, Lee YA, Kim YH, Hong SJ, Yang HI, Lee SH (2009) The use of etanercept in a patient with disseminated tuberculosis. Rheumatol Int 29(11):1377\u20131380","journal-title":"Rheumatol Int"},{"issue":"5","key":"1903_CR11","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/cid\/ciq213","volume":"52","author":"ML Ramien","year":"2011","unstructured":"Ramien ML, Wong A, Keystone JS (2011) Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept. Clin Infect Dis 52(5):e133\u2013e155","journal-title":"Clin Infect Dis"},{"key":"1903_CR12","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/keq264","volume":"49","author":"S Chauhan","year":"2010","unstructured":"Chauhan S, Wakhlu A, Agarwal V (2010) Arthritis in leprosy. Rheumatology 49:2237\u20132242","journal-title":"Rheumatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1903-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1903-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1903-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:53Z","timestamp":1559105513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1903-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1903-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}